Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rangering i aksjer #32247
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Aksjekurs
$0.8013
Sist synkronisert: 2026-08-05
Markedsverdi
$10.62M
Endring (1 dag)
0.97%
Endring (1 år)
-37.88%
Land
US
Handel Hoth Therapeutics, Inc. (HOTH)

Kategori

Historikk for aksjesplitt for Hoth Therapeutics, Inc. (HOTH)
Aksjen Hoth Therapeutics, Inc. (symbol: HOTH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én HOTH-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 HOTH-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR